These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 4386073)

  • 21. Effects of a hydrazine monoamine oxidase inhibitor (phenelzine) on isoproterenol-induced myocardiopathies in the rat.
    Stanton HC; Schwartz A
    J Pharmacol Exp Ther; 1967 Sep; 157(3):649-58. PubMed ID: 6048021
    [No Abstract]   [Full Text] [Related]  

  • 22. EFFECT OF ISONIAZID AND OTHER HYDRAZINE DERIVATIVES ON THE METABOLISM OF METHANOL.
    KOIVUSALO M
    Ann Med Exp Biol Fenn; 1963; 41():247-50. PubMed ID: 14085803
    [No Abstract]   [Full Text] [Related]  

  • 23. Experimental pathology of iproniazid and related compounds.
    ZBINDEN G; STUDER A
    Ann N Y Acad Sci; 1959 Sep; 80():873-84. PubMed ID: 13847126
    [No Abstract]   [Full Text] [Related]  

  • 24. Cardiac death prevention in post-myocardial infarction patients: a review.
    Boissel JP; Leizorovicz A; Faucomprez C
    Acta Cardiol Suppl; 1980; (25):147-79. PubMed ID: 6103625
    [No Abstract]   [Full Text] [Related]  

  • 25. Central effects of beta-phenylisopropylhydrazine and iproniazid.
    FURGIUELE AR; KINNARD WJ; BUCKLEY JP
    J Pharmacol Exp Ther; 1962 Sep; 137():356-60. PubMed ID: 13895937
    [No Abstract]   [Full Text] [Related]  

  • 26. [The effect of hydrazine and isonicotinic acid hydrazide on certain substances of sugar metabolism in vitro].
    Krulík R
    Arzneimittelforschung; 1966 Dec; 16(12):1623-6. PubMed ID: 6014797
    [No Abstract]   [Full Text] [Related]  

  • 27. Inhibition of diamine oxidase in vivo by hydrazine derivatives.
    BURKARD WP; GEY KF; PLETSCHER A
    Biochem Pharmacol; 1960 Jul; 3():249-55. PubMed ID: 13806127
    [No Abstract]   [Full Text] [Related]  

  • 28. [Coronary arteries and myocardial perfusion in experimental acute vascular occlusion. Influence of pharmacological coronary dilatation].
    Hahn N; Felix R; Draznin N; Mayer R; Düx A; Sporbeck G
    Med Welt; 1971 Oct; 44():1738-40. PubMed ID: 5125834
    [No Abstract]   [Full Text] [Related]  

  • 29. [Cerebral circulatory and cochleovestibular manifestations of isoniazid and iproniazid].
    RISER M; GAYRAL L; GERAUD J; COLL J; TURNIN J
    Rev Neurol (Paris); 1959 Nov; 101():610-8. PubMed ID: 14437548
    [No Abstract]   [Full Text] [Related]  

  • 30. Serotonin degradation by ceruloplasmin and its inhibition by isoniazid and iproniazid.
    ZARAFONETIS CJ; KALAS JP
    Am J Med Sci; 1960 Feb; 239():203-6. PubMed ID: 13847033
    [No Abstract]   [Full Text] [Related]  

  • 31. [The effect of Visnadine in chronic degenerative myocardial lesions].
    Bargheer R; Fiegel G; Saito S; Guttmann W
    Arzneimittelforschung; 1967 Mar; 17(3):288-90. PubMed ID: 5631219
    [No Abstract]   [Full Text] [Related]  

  • 32. [Pharmacologic prevention of fibrillation in acute ischemia of the heart and the dynamics of electrolytes].
    Popova NK; Ivashkevich EI
    Biull Eksp Biol Med; 1965 May; 59(5):64-7. PubMed ID: 5880812
    [No Abstract]   [Full Text] [Related]  

  • 33. [The influence of iproniazid and beta-phenylisopropylhydrazine (JB516) on the narcotic effect and decomposition of hexobarbital and thiopental].
    ARRIGONI-MARTELLI E; KRAMER M
    Med Exp Int J Exp Med; 1959; 1():45-51. PubMed ID: 13794503
    [No Abstract]   [Full Text] [Related]  

  • 34. The importance of ammonia in the metabolic effects of hydrazine.
    Floyd WN
    Aviat Space Environ Med; 1980 Sep; 51(9 Pt 1):899-901. PubMed ID: 7417161
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Some cardiovascular actions of iproniazid and pyrogallol.
    Sogani RK; Sharma VN
    Indian J Physiol Pharmacol; 1965 Jul; 9(3):103-10. PubMed ID: 5887639
    [No Abstract]   [Full Text] [Related]  

  • 36. A simple microassay for the determination of hydrazine in biological samples. Effect of hydrazine and isoniazid on liver and brain glutathione.
    Alvarez de Laviada T; Romero FJ; Antón V; Antón V; Romá J; Viña J; Sáez GT
    J Anal Toxicol; 1987; 11(6):260-2. PubMed ID: 3431095
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Methods of direct registration of collateral coronary circulation and problem of pharmacological stimulation of collateral circulation in the heart. (Review of the literature and laboratory studies)].
    Gatsura VV
    Farmakol Toksikol; 1969; 32(1):110-5. PubMed ID: 4388893
    [No Abstract]   [Full Text] [Related]  

  • 38. [Pharmacology of hydrazinocarbonic acids, hydrazinopeptides and various hydrazine derivatives. IV. Anticonvulsive effects of aliphatic hydrazinocarbonic acids, peptides containing these heteroconstituents and of other hydrazine derivatives].
    Oehme P; Hartmann R; Friedrich U; Schwarz C
    Acta Biol Med Ger; 1969; 23(1):189-201. PubMed ID: 5373958
    [No Abstract]   [Full Text] [Related]  

  • 39. Hydrazide derivatives produce active oxygen species as hydrazine.
    Timperio AM; Rinalducci S; Zolla L
    Bioorg Chem; 2005 Dec; 33(6):459-69. PubMed ID: 16260027
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Apropos of the mechanism of action of monoamine oxidase-inhibitors on the coronary circulation].
    Mirzoian RS
    Farmakol Toksikol; 1965; 28(1):51-5. PubMed ID: 5845043
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.